Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis

Monzavi‑Karbassi,Behjatolah; Siegel,Eric R.; Medarametla,Srikanth; Makhoul,Issam; Kieber‑Emmons,Thomas

doi:10.3892/ol.2016.4804

Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis

Authors:
- Behjatolah Monzavi‑Karbassi
- Eric R. Siegel
- Srikanth Medarametla
- Issam Makhoul
- Thomas Kieber‑Emmons
View Affiliations

Affiliations: Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA, Division of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Published online on: June 29, 2016 https://doi.org/10.3892/ol.2016.4804
Pages: 1337-1342
Copyright: © Monzavi‑Karbassi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite progress in breast cancer treatment, disparity persists in survival time between African American (AA) and Caucasian women in the US. Tumor stage and tumor grade are the major prognostic factors that define tumor aggressiveness and contribute to racial disparity between AA and Caucasian women. Studying the interaction of race with tumor grade or stage may provide further insights into the role of intrinsic biological aggressiveness in disecting the AA‑Caucasian survival disparity. Therefore, the current study was performed to evaluate the interaction of race with tumor grade and stage at diagnosis regarding survival in a cohort of patients treated at the Winthrop P. Rockefeller Cancer Institute of the University of Arkansas for Medical Sciences (Little Rock, AR, USA). The cohort included 1,077 patients, 208 (19.3%) AA and 869 (80.7%) Caucasian, diagnosed with breast cancer between January 1997 and December 2005. Kaplan‑Meier survival plots were generated and Cox regressions were performed to analyze the associations of race with breast cancer‑specific survival time. Over a mean follow‑up time of 1.5 years, AA women displayed increased mortality risk due to breast cancer‑specific causes [hazard ratio (HR), 1.74; 95% confidence interval (CI), 1.23‑2.46]. The magnitude of racial disparity varied strongly with tumor grade (race‑x‑grade interaction; P<0.001). No significant interaction was observed between race and tumor stage or race and age at diagnosis. Among women diagnosed with grade I tumors, the race disparity in survival time after controlling for tumor stage and age was strong (HR, 9.07; 95% CI, 2.11‑38.95), but no significant AA‑Caucasian disparity was observed among women with higher‑grade tumors. The data suggest that, when diagnosed with grade I breast cancer, AA may experience poorer survival outcomes compared with Caucasian patients, regardless of tumor stage or age. The findings potentially provide significant clinical and public health implications and justify further investigation.

View Figures

View References

1	American Cancer Society: Cancer Facts & Figures 2015. American Cancer Society, Inc. Atlanta, GA: 2015.
2	Ademuyiwa FO and Olopade OI: Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev. 22:47–53. 2003. View Article : Google Scholar : PubMed/NCBI
3	Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, et al: Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst. 97:439–448. 2005. View Article : Google Scholar : PubMed/NCBI
4	Polite BN and Olopade OI: Breast cancer and race: A rising tide does not lift all boats equally. Perspect Biol Med. 48(Suppl 1): S166–S175. 2005. View Article : Google Scholar : PubMed/NCBI
5	American Cancer Society: Breast Cancer Facts & Figures 2013–2014. American Cancer Society, Inc. Atlanta, GA: 2013.
6	Keeton KM, Jones ES and Sebastian S: Breast cancer in Mississippi: Impact of race and residential geographical setting on cancer at initial diagnosis. South Med J. 107:510–512. 2014. View Article : Google Scholar : PubMed/NCBI
7	DeLancey JO, Thun MJ, Jemal A and Ward EM: Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev. 17:2908–2912. 2008. View Article : Google Scholar : PubMed/NCBI
8	Hunt BR, Whitman S and Hurlbert MS: Increasing black: White disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 38:118–123. 2014. View Article : Google Scholar : PubMed/NCBI
9	McCarthy AM, Yamartino P, Yang J, Bristol M, Conant EF and Armstrong K: Racial differences in false-positive mammogram rates: Results from the ACRIN digital mammographic imaging screening trial (DMIST). Med Care. 53:673–678. 2015. View Article : Google Scholar : PubMed/NCBI
10	Li CI, Malone KE and Daling JR: Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 163:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
11	Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ and Eley JW: Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 100:2533–2542. 2004. View Article : Google Scholar : PubMed/NCBI
12	Amend K, Hicks D and Ambrosone CB: Breast cancer in African-American women: Differences in tumor biology from European-American women. Cancer Res. 66:8327–8330. 2006. View Article : Google Scholar : PubMed/NCBI
13	Sarker M, Jatoi I and Becher H: Racial differences in breast cancer survival in women under age 60. Breast Cancer Res Treat. 106:135–141. 2007. View Article : Google Scholar : PubMed/NCBI
14	Baquet CR, Mishra SI, Commiskey P, Ellison GL and DeShields M: Breast cancer epidemiology in blacks and whites: Disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 100:480–488. 2008. View Article : Google Scholar : PubMed/NCBI
15	Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, et al: Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Res. 12:2072010.PubMed/NCBI
16	Soerjomataram I, Louwman MW, Ribot JG, Roukema JA and Coebergh JW: An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 107:309–330. 2008. View Article : Google Scholar : PubMed/NCBI
17	Henson DE, Chu KC and Levine PH: Histologic grade, stage and survival in breast carcinoma: Comparison of African American and Caucasian women. Cancer. 98:908–917. 2003. View Article : Google Scholar : PubMed/NCBI
18	Cunningham JE and Butler WM: Racial disparities in female breast cancer in South Carolina: Clinical evidence for a biological basis. Breast Cancer Res Treat. 88:161–176. 2004. View Article : Google Scholar : PubMed/NCBI
19	Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). Springer-Verlag. New York, NY: 2010.
20	Albain KS, Unger JM, Crowley JJ, Coltman CA Jr and Hershman DL: Racial disparities in cancer survival among randomized clinical trials patients of the southwest oncology group. J Natl Cancer Inst. 101:984–992. 2009. View Article : Google Scholar : PubMed/NCBI
21	Mancino AT, Rubio IT, Henry-Tillman R, Smith LF, Landes R, Spencer HJ, Erkman L and Klimberg VS: Racial differences in breast cancer survival: The effect of residual disease. J Surg Res. 100:161–165. 2001. View Article : Google Scholar : PubMed/NCBI
22	Danforth DN Jr: Disparities in breast cancer outcomes between Caucasian and African American women: A model for describing the relationship of biological and nonbiological factors. Breast Cancer Res. 15:2082013. View Article : Google Scholar : PubMed/NCBI
23	Iqbal J, Ginsburg O, Rochon PA, Sun P and Narod SA: Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 313:165–173. 2015. View Article : Google Scholar : PubMed/NCBI
24	Balan V, Nangia-Makker P, Schwartz AG, Jung YS, Tait L, Hogan V, Raz T, Wang Y, Yang ZQ, Wu GS, et al: Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): A pilot study. Cancer Res. 68:10045–10050. 2008. View Article : Google Scholar : PubMed/NCBI
25	Field LA, Love B, Deyarmin B, Hooke JA, Shriver CD and Ellsworth RE: Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer. 118:1334–1344. 2012. View Article : Google Scholar : PubMed/NCBI
26	Singh Kalla S, Tan QW, Brito C, De León M and De León D: Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women. Growth Horm IGF Res. 20:245–254. 2010. View Article : Google Scholar : PubMed/NCBI
27	Stewart PA, Luks J, Roycik MD, Sang QX and Zhang J: Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer. PLoS One. 8:e824602013. View Article : Google Scholar : PubMed/NCBI
28	Quan L, Gong Z, Yao S, Bandera EV, Zirpoli G, Hwang H, Roberts M, Ciupak G, Davis W, Sucheston L, et al: Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry. Int J Cancer. 134:1408–1421. 2014. View Article : Google Scholar : PubMed/NCBI
29	Walko CM, Combest AJ, Spasojevic I, Yu AY, Bhushan S, Hull JH, Hoskins J, Armstrong D, Carey L, Collicio F and Dees EC: The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer Chemother Pharmacol. 69:1189–1196. 2012. View Article : Google Scholar : PubMed/NCBI
30	Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC and Hutchins LF: Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 38:74–79. 2015. View Article : Google Scholar : PubMed/NCBI
31	Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW and Coates RJ: Racial differences in diagnosis, treatment and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 100:1595–1604. 2004. View Article : Google Scholar : PubMed/NCBI
32	George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV and Demissie K: Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt). 24:209–2017. 2015. View Article : Google Scholar : PubMed/NCBI
33	Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC and Lyman GH: Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol. 25:2522–2527. 2007. View Article : Google Scholar : PubMed/NCBI
34	Partridge AH, Wang PS, Winer EP and Avorn J: Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 21:602–606. 2003. View Article : Google Scholar : PubMed/NCBI
35	Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K and Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: A single-institution compilation compared with the national cancer institute's surveillance, epidemiology and end results database. Cancer. 110:876–884. 2007. View Article : Google Scholar : PubMed/NCBI
36	Barcenas CH, Wells J, Chong D, French J, Looney SW and Samuel TA: Race as an independent risk factor for breast cancer survival: Breast cancer outcomes from the medical college of georgia tumor registry. Clin Breast Cancer. 10:59–63. 2010. View Article : Google Scholar : PubMed/NCBI
37	Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD Jr, Dewitty RL Jr and Frederick WA: Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women. Am J Surg. 195:153–158. 2008. View Article : Google Scholar : PubMed/NCBI
38	Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L and Frederick WA: Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: Age-specific prevalence and survival. J Surg Res. 143:109–118. 2007. View Article : Google Scholar : PubMed/NCBI
39	Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG and Eley JW: Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA. Breast Cancer Res Treat. 113:357–370. 2009. View Article : Google Scholar : PubMed/NCBI
40	Menashe I, Anderson WF, Jatoi I and Rosenberg PS: Underlying causes of the black-white racial disparity in breast cancer mortality: A population-based analysis. J Natl Cancer Inst. 101:993–1000. 2009. View Article : Google Scholar : PubMed/NCBI
41	Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD and Zhu K: Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: An analysis of the surveillance, epidemiology and end results data. Cancer Causes Control. 25:959–968. 2014. View Article : Google Scholar : PubMed/NCBI
42	Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, et al: Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
43	Bentzon N, Düring M, Rasmussen BB, Mouridsen H and Kroman N: Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer. 122:1089–1094. 2008. View Article : Google Scholar : PubMed/NCBI